Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use

Context: Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are a novel treatment approved for type 2 diabetes mellitus to lower hyperglycemia, systolic blood pressure, and promote weight loss. Commonly reported serious adverse events include increased mycotic urogenital infections, orthostatic hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Melnick, Stephen, Rajagopalan, Priya, Lynn, Theresa, Donato, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197014/
https://www.ncbi.nlm.nih.gov/pubmed/30357044
http://dx.doi.org/10.1080/20009666.2018.1527667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197014/
https://www.ncbi.nlm.nih.gov/pubmed/30357044
http://dx.doi.org/10.1080/20009666.2018.1527667

Ejemplares similares